Virtus ETF Advisers LLC Novavax Inc Transaction History

Virtus ETF Advisers LLC

$234 Million
Q4 2024

A detailed history of Virtus ETF Advisers LLC transactions in Novavax Inc stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 38,765 shares of NVAX stock, worth $271,355. This represents 0.13% of its overall portfolio holdings.

Number of Shares

38,765

Previous 21,884 77.14%

Holding current value

$271,355

Previous $276,000 12.68%

% of portfolio

0.13%

Previous 0.13%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$7.22 - $14.68 $121,880 - $247,813	16,881 Added 77.14%	38,765 $311,000
Q2 2024 Aug 14, 2024	BUY	$3.89 - $20.97 $25,891 - $139,576	6,656 Added 43.71%	21,884 $277,000
Q1 2024 May 15, 2024	SELL	$3.76 - $6.02 $3,921 - $6,278	-1,043 Reduced 6.41%	15,228 $72,000
Q4 2023 Feb 15, 2024	BUY	$4.8 - $7.67 $16,598 - $26,522	3,458 Added 26.99%	16,271 $78,000
Q3 2023 Nov 07, 2023	SELL	$6.81 - $9.74 $8,662 - $12,389	-1,272 Reduced 9.03%	12,813 $92,000
Q2 2023 Aug 14, 2023	BUY	$6.67 - $9.52 $54,774 - $78,178	8,212 Added 139.83%	14,085 $104,000
Q1 2023 May 15, 2023	SELL	$5.76 - $12.48 $12,994 - $28,154	-2,256 Reduced 27.75%	5,873 $40,000
Q4 2022 Feb 14, 2023	BUY	$8.86 - $25.04 $48,162 - $136,117	5,436 Added 201.86%	8,129 $83,000
Q3 2022 Nov 14, 2022	BUY	$18.2 - $76.12 $254 - $1,065	14 Added 0.52%	2,693 $49,000
Q2 2022 Aug 12, 2022	BUY	$36.28 - $75.29 $63,780 - $132,359	1,758 Added 190.88%	2,679 $138,000
Q1 2022 May 16, 2022	SELL	$69.73 - $142.9 $3,765 - $7,716	-54 Reduced 5.54%	921 $68,000
Q4 2021 Feb 14, 2022	SELL	$134.56 - $217.97 $7,131 - $11,552	-53 Reduced 5.16%	975 $139,000
Q3 2021 Nov 15, 2021	SELL	$177.8 - $270.58 $8,712 - $13,258	-49 Reduced 4.55%	1,028 $213,000
Q2 2021 Aug 10, 2021	SELL	$121.0 - $257.67 $148,951 - $317,191	-1,231 Reduced 53.34%	1,077 $229,000
Q1 2021 May 17, 2021	BUY	$112.98 - $319.93 $3,728 - $10,557	33 Added 1.45%	2,308 $418,000
Q4 2020 Feb 12, 2021	SELL	$78.74 - $139.5 $353,621 - $626,494	-4,491 Reduced 66.38%	2,275 $254,000
Q3 2020 Nov 13, 2020	SELL	$79.44 - $178.51 $73,561 - $165,300	-926 Reduced 12.04%	6,766 $733,000
Q2 2020 Aug 05, 2020	BUY	$13.86 - $83.61 $106,611 - $643,128	7,692 New	7,692 $641,000

Others Institutions Holding NVAX

# of Institutions

284

Shares Held

93.7M

Call Options Held

5.4M

Put Options Held

8.76M

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $548M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Account

Virtus ETF Advisers LLC Novavax Inc Transaction History